Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.
Edwards NC; Rupnow MF; Pashos CL; Botteman MF; Diamond RJ; Pharmacoeconomics, 2005, vol. 23, issue 3, p 299, ISSN 11707690. ISBN 11707690.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef